Next Article in Journal
A Study of Frailty, Mortality, and Health Depreciation Factors in Older Adults
Next Article in Special Issue
Dynamic Transmission of Staphylococcus Aureus in the Intensive Care Unit
Previous Article in Journal
Breast Cancer Gone Viral? Review of Possible Role of Bovine Leukemia Virus in Breast Cancer, and Related Opportunities for Cancer Prevention
Previous Article in Special Issue
Is Post-Reprocessing Microbiological Surveillance of Duodenoscopes Effective in Reducing the Potential Risk in Transmitting Pathogens?
 
 
Article

Association of Drug Metabolic Enzyme Genetic Polymorphisms and Adverse Drug Reactions in Patients Receiving Rifapentine and Isoniazid Therapy for Latent Tuberculosis

1
Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan
2
Department of Clinical Laboratory, Changhua Hospital, Changhua 513, Taiwan
3
Division of Chest, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung 402, Taiwan
4
Institute of Biochemistry, Microbiology and Immunology, Chung Shan Medical University, Taichung 402, Taiwan
5
Department of Internal Medicine, Taichung Hospital, Ministry of Health and Welfare, Taichung 403, Taiwan
6
Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung 407, Taiwan
7
Department of Medical Technology, Jen-Teh Junior College of Medicine, Nursing and Management, Miaoli 356, Taiwan
8
Department of Life Sciences, National Chung Hsing University, Taichung 402, Taiwan
9
Department of Industrial Engineering and Enterprise Information, Tunghai University, Taichung 407, Taiwan
10
Division of Chest, Changhua Christian Hospital, Changhua 500, Taiwan
11
Department of Health, Pulmonary and Critical Care Unit, Changhua Hospital, Changhua 500, Taiwan
12
Department of Medical Research, Chung Shan Medical University Hospital, Taichung 402, Taiwan
13
School of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung 402, Taiwan
14
Department of Clinical Laboratory, Chung Shan Medical University Hospital, Taichung 402, Taiwan
*
Authors to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2020, 17(1), 210; https://doi.org/10.3390/ijerph17010210
Received: 11 November 2019 / Revised: 24 December 2019 / Accepted: 25 December 2019 / Published: 27 December 2019
(This article belongs to the Special Issue Healthcare Infections and Prevention )
Weekly rifapentine and isoniazid therapy (3HP) is the most frequent treatment for latent tuberculosis infection (LTBI). However, the association between major adverse drug reactions (ADRs) and drug metabolic enzyme single-nucleotide polymorphisms (SNPs) remains unclear. In this study, 377 participants who received the 3HP regimen were recruited and examined for genotyping of CYP5A6, CYP2B6, CYP2C19, CYP2E1, and NAT2 SNPs. In our study, 184 participants (48.4%) developed ADRs. Moreover, CYP2C19 rs4986893 (TT vs. CC+CT, odds ratio [OR] [95% CI]: 2.231 [1.015–4.906]), CYP2E1 rs2070676 (CC vs. CG+GG, OR [95% CI]: 1.563 [1.022–2.389]), and CYP2E1 rs2515641 (CC vs. CT+TT, OR [95% CI]: 1.903 [1.250–2.898]) were associated with ADR development. In conclusion, CYP2C19 and CYP2E1 SNPs may provide useful information regarding ADRs in LTBI patients receiving the 3HP regimen. View Full-Text
Keywords: drug metabolic enzymes; polymorphism; latent tuberculosis; adverse drug reaction drug metabolic enzymes; polymorphism; latent tuberculosis; adverse drug reaction
MDPI and ACS Style

Yu, Y.-Y.; Tsao, S.-M.; Yang, W.-T.; Huang, W.-C.; Lin, C.-H.; Chen, W.-W.; Yang, S.-F.; Chiou, H.-L.; Huang, Y.-W. Association of Drug Metabolic Enzyme Genetic Polymorphisms and Adverse Drug Reactions in Patients Receiving Rifapentine and Isoniazid Therapy for Latent Tuberculosis. Int. J. Environ. Res. Public Health 2020, 17, 210. https://doi.org/10.3390/ijerph17010210

AMA Style

Yu Y-Y, Tsao S-M, Yang W-T, Huang W-C, Lin C-H, Chen W-W, Yang S-F, Chiou H-L, Huang Y-W. Association of Drug Metabolic Enzyme Genetic Polymorphisms and Adverse Drug Reactions in Patients Receiving Rifapentine and Isoniazid Therapy for Latent Tuberculosis. International Journal of Environmental Research and Public Health. 2020; 17(1):210. https://doi.org/10.3390/ijerph17010210

Chicago/Turabian Style

Yu, Ya-Yen, Shih-Ming Tsao, Wen-Ta Yang, Wei-Chang Huang, Ching-Hsiung Lin, Wei-Wen Chen, Shun-Fa Yang, Hui-Ling Chiou, and Yi-Wen Huang. 2020. "Association of Drug Metabolic Enzyme Genetic Polymorphisms and Adverse Drug Reactions in Patients Receiving Rifapentine and Isoniazid Therapy for Latent Tuberculosis" International Journal of Environmental Research and Public Health 17, no. 1: 210. https://doi.org/10.3390/ijerph17010210

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop